Startup
MT
Metagen Therapeutics
Therapeutics based on gut microbiota.
Funding rounds
Grey amounts aren't counted in totals. † includes debt or other non-equity.
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 4 Sept 2026 | MTMetagen Therapeutics | Series B extension (1st close) | ¥190M | 15th Rock | BiotechDeep tech |
| 26 Feb 2026 | MTMetagen Therapeutics | Series B | ¥3.5B | Canon Marketing Japan MIRAI FundMatsukiyoCocokara & CompanyMedipal Holdings | BiotechDeep tech |